You have 9 free searches left this month | for more free features.

Levodopa

Showing 1 - 25 of 838

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Parkinson, Parkinson Disease, Parkinson's Disease and Parkinsonism Trial in Sofia (Levodopa Cyclops™, INBRIJA®)

Not yet recruiting
  • Parkinson
  • +2 more
  • Levodopa Cyclops™
  • INBRIJA®
  • Sofia, Bulgaria
    Bed space for short term stay at Diagnostic & Consultative Centr
Sep 13, 2023

Healthy Trial (Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets

Not yet recruiting
  • Healthy
  • Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
  • Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)
  • (no location specified)
Jul 26, 2023

Reduction of Levodopa and Non-motor Symptoms of Parkinson's

Completed
  • Parkinson Disease
  • Visual Impairment
  • Levodopa
  • Jinan, Sichuan, China
    Chao Zhang
Jun 4, 2023

Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)

Enrolling by invitation
  • Parkinson Disease
  • Treatment Adherence
  • Levodopa
  • Ankara, Turkey
    Ankara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023

Levodopa-Induced Dyskinesia, Parkinson's Disease Trial in Tucson (Intervention: Ketamine)

Active, not recruiting
  • Levodopa-Induced Dyskinesia
  • Parkinson's Disease
  • Intervention: Ketamine
  • Tucson, Arizona
    Scott J Sherman
Aug 27, 2023

Parkinson Disease Trial in Rome (Continuous theta burst stimulation)

Recruiting
  • Parkinson Disease
  • Continuous theta burst stimulation
  • Rome, Italy
    Flavia Torlizzi
Mar 20, 2023

Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,

Not yet recruiting
  • Idiopathic Parkinson Disease
  • levodopa/carbidopa oral formulation A
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota
Jul 20, 2022

Parkinson Disease Trial in Dhaka (Folic Acid Tablet, Placebo)

Recruiting
  • Parkinson Disease
  • Folic Acid Tablet
  • Placebo
  • Dhaka, Bangladesh
    BSMMU
Jul 15, 2023

Depression Trial in Atlanta (Levodopa+carbidopa, Placebo)

Completed
  • Depression
  • Atlanta, Georgia
    Emory University Hospital
Aug 24, 2022

Parkinson Disease, Orthostatic Hypotension Trial in Salt Lake City (Autonomic testing on and off levodopa)

Recruiting
  • Parkinson Disease
  • Orthostatic Hypotension
  • Autonomic testing on and off levodopa
  • Salt Lake City, Utah
    University of Utah
Aug 1, 2022

Parkinson Disease Trial in San Diego (Levodopameter)

Recruiting
  • Parkinson Disease
  • Levodopameter
  • San Diego, California
    University of California San DIego
Nov 1, 2022

Levodopa-induced Dyskinesia, Parkinson's Disease Trial in Bunkyo (DSP-9632P 27.5 mg, DSP-9632P 82.5 mg, Placebo)

Recruiting
  • Levodopa-induced Dyskinesia
  • Parkinson's Disease
  • DSP-9632P 27.5 mg
  • +4 more
  • Bunkyo, Tokyo, Japan
    Nippon Medical School Hospital
Jun 23, 2022

Preventing Levodopa Induced Dyskinesia in Parkinson's Disease

Recruiting
  • Parkinson Disease
  • Dyskinesia, Drug-Induced
  • Intravenous Infusion
  • Portland, Oregon
  • +2 more
Dec 23, 2022

Parkinson Disease Trial in Rome (Transcranial direct current stimulation)

Recruiting
  • Parkinson Disease
  • Transcranial direct current stimulation
  • Rome, Italy
    Flavia Torlizzi
Feb 21, 2023

Usability of Levodopa Cyclops™ vs INBRIJA® in Parkinson's

Not yet recruiting
  • Usability
  • Inhalation maneuver with placebo Inbrija and placebo Cyclops
  • (no location specified)
Aug 11, 2022

DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy to

Not yet recruiting
  • Parkinson Disease
    • (no location specified)
    Oct 14, 2022

    Parkinson Disease Trial in Dhaka (Doxycycline, Placebo)

    Recruiting
    • Parkinson Disease
    • Dhaka, Bangladesh
      Bangabandhu Sheikh Mujib Medical University (BSMMU)
    Aug 4, 2022

    Parkinson Disease Trial in Bern, Geneva (Dopaminergic OFF-drug state, Dopaminergic ON-drug state)

    Recruiting
    • Parkinson Disease
    • Dopaminergic OFF-drug state
    • Dopaminergic ON-drug state
    • Bern, Switzerland
    • +3 more
    Jan 11, 2023

    Parkinson Disease Trial in Rome (Standard LD/CD, Semi continuous intra-oral administration of LD/CD)

    Completed
    • Parkinson Disease
    • Standard LD/CD
    • Semi continuous intra-oral administration of LD/CD
    • Rome, Italy
      Irccs San Raffaele Pisana
    Oct 17, 2022

    Parkinson's Disease Trial in Amsterdam (Continuous intrajejunal infusion of levodopa-carbidopa, deep brain stimulation)

    Active, not recruiting
    • Parkinson's Disease
    • Continuous intrajejunal infusion of levodopa-carbidopa
    • deep brain stimulation
    • Amsterdam, Noord Holland, Netherlands
      Academic Medical Center
    Apr 20, 2022

    Parkinson Disease Trial in Cleveland (Neurostimulation, Carbidopa 25/Levodopa 100Mg Tab)

    Recruiting
    • Parkinson Disease
    • Neurostimulation
    • Carbidopa 25/Levodopa 100Mg Tab
    • Cleveland, Ohio
      Cleveland Clinic
    Aug 25, 2023

    Bioequivalence Trial in Chennai (Levodopa 250mg and Carbidopa 25mg Test Drug tablet, Levodopa 250mg and Carbidopa 25mg Referent

    Completed
    • Bioequivalence
    • Levodopa 250mg and Carbidopa 25mg Test Drug tablet
    • Levodopa 250mg and Carbidopa 25mg Referent Product tablet
    • Chennai, Tamil Nadu, India
      Azidus Laboratories Ltd.
    Mar 7, 2022

    Parkinson Disease Trial in Mansoura (levodopa-carbidopa, Montelukast)

    Not yet recruiting
    • Parkinson Disease
    • Mansoura, Egypt
      Faculty of Medicine, Mansoura University
    Oct 28, 2023

    Parkinson Disease Trial in Ahmedabad (WD-1603 Carbidopa-Levodopa Extended-Release Tablets)

    Recruiting
    • Parkinson Disease
    • WD-1603 Carbidopa-Levodopa Extended-Release Tablets
    • Ahmedabad, Gujarat, India
      Lambda Therapeutic Research Ltd.
    Nov 10, 2021

    Chronic Pain Trial in Rochester (Methylphenidate, carbidopa-levodopa, Placebo)

    Recruiting
    • Chronic Pain
    • Rochester, New York
      University of Rochester Medical Center
    Jan 9, 2023